Clinical Rheumatology

, Volume 26, Issue 1, pp 24–29 | Cite as

Functional disability and health-related quality of life in South Africans with rheumatoid arthritis and systemic lupus erythematosus

Original Article

Abstract

There is a paucity of data on the impact of chronic rheumatic diseases on functional disability and overall health-related quality of life (HRQOL) in Africans. Materials and methods: We compared Black South Africans (BSA) with rheumatoid arthritis (RA) (n=50) and systemic lupus erythematosus (SLE) (n=50) to geographically and ethnically matched controls cared for at a tertiary care facility. The modified health assessment questionnaire (mHAQ) and Medical Outcome Study short-form 36 (SF-36) scores and indices of disease activity and organ damage were collected from each group. Results: Compared to the controls, both the RA and SLE groups fared significantly worse in respect of all the domains and summary scales of the SF-36. Compared to the SLE group, the RA group scored significantly worse with respect to the mHAQ disability index (mHAQ-DI), physical function and bodily pain (BP) SF-36 subscales, and SF-36 summary physical component score (SF-PCS). In the RA group, both the mHAQ-DI and SF-PCS correlated strongly (p<0.005) with the tender joint count, patient global assessment, 28-joint composite disease activity score, physician global assessment, and pain score. The SF-PCS showed only a weak inverse correlation with the swollen joint count (r=−0.29, p<0.05). In the SLE group, the systemic lupus erythematosus disease activity index correlated inversely best with the SF-36 general health subscale (r=−0.56, p<0.0001) and, to a lesser extent, with the mental health, BP, and vitality subscales, and SF-PCS and SF-mental component summary scores. Conclusion: Both RA and SLE have profound effects on HRQOL in BSA, with BP and physical disability particularly worse in RA patients. Disease activity, rather than organ damage or sociodemographic characteristics, correlates best with certain aspects of functional disability and HRQOL in both RA and SLE. Further longitudinal studies are needed to assess the clinical utility of measures of functional disability and HRQOL in this population.

Keywords

Africa Functional disability Quality of life Rheumatoid arthritis Systemic lupus erythematosus 

Notes

Acknowledgement

RB was funded by the Medical Endowment Fund, University of the Witwatersrand. We would like to thank Dr. Matthew Liang for his expert advice.

References

  1. 1.
    Kvien TK (2004) Epidemiology and burden of illness of rheumatoid arthritis. Pharmacoeconomics 22(Suppl 2):1–12PubMedGoogle Scholar
  2. 2.
    Pincus T, Brooks RH, Callahan LF (1994) Prediction of long-term mortality in patients with rheumatoid arthritis according to simple questionnaire and joint count measures. Ann Intern Med 120:26–34PubMedGoogle Scholar
  3. 3.
    Isenberg D, Ramsey-Goldman C (1999) Assessing patients with lupus: towards a drug responder index. Rheumatology 38:1945–1949CrossRefGoogle Scholar
  4. 4.
    Pincus T, Summey J, Soraci SJ, Wallston K, Hummon N (1983) Assessment of patient satisfaction in activities of daily living using a modified Stanford health assessment questionnaire. Arthritis Rheum 26:1346–1353PubMedCrossRefGoogle Scholar
  5. 5.
    Ware JE, Gandek B (1998) Overview of the SF-36 health survey and the international quality of life assessment (IQOLA) project. J Clin Epidemiol 51:903–912PubMedCrossRefGoogle Scholar
  6. 6.
    McEntergart A, Morrison E, Capell HA, Duncan MR, Porter D, Madhok R et al (1997) The effect of social deprivation on disease severity and outcome in patients with rheumatoid arthritis. Ann Rheum Dis 56:410–413Google Scholar
  7. 7.
    Karlson EW, Daltroy LH, Lew RA, Wright EA, Patridge AJ, Fossel AH et al (1997) The relationship of socioeconomic status, race, and modifiable risk factors to outcomes in patients with systemic lupus erythematosus. Arthritis Rheum 40:47–56PubMedCrossRefGoogle Scholar
  8. 8.
    Alarcon GS, McGwin G, Jr, Uribe A, Friedman AW, Roseman JM, Fessler BJ et al (2004) Systemic lupus erythematosus in a multiethnic lupus cohort (LUMINA). XVII. Predictors of self-reported health-related quality of life early in the disease course. Arthritis Rheum 51:465–474PubMedCrossRefGoogle Scholar
  9. 9.
    Mody GM, Shaw J, Ramchurren A (1988) Rheumatoid arthritis impact survey. S Afr Med J 74:409–410PubMedGoogle Scholar
  10. 10.
    Tikly M, Zannettou N, Hopley M (2003) A longitudinal study of rheumatoid arthritis in South Africans. MedGenMed 5(1):2PubMedGoogle Scholar
  11. 11.
    Tikly M, Burgin S, Mohanlal P, Bellingan A, George J (1996) Autoantibodies in black South Africans with systemic lupus erythematosus: spectrum and clinical associations. Clin Rheumatol 15:261–265PubMedCrossRefGoogle Scholar
  12. 12.
    Lalloo R, Myburgh NG, Smith MJ, Solanki GC (2004) Access to health care in South Africa—the influence of race and class. S Afr Med J 94:639–642PubMedGoogle Scholar
  13. 13.
    Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS et al (1987) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315–324CrossRefGoogle Scholar
  14. 14.
    Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF et al (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271–1277PubMedCrossRefGoogle Scholar
  15. 15.
    Smolen JS, Breedveld FC, Eberl G et al (1995) Validity and reliability of the twenty-eight-joint count for the assessment of rheumatoid arthritis activity. Arthritis Rheum 32:531–537Google Scholar
  16. 16.
    Larsen A, Dale K, Eek M (1977) Radiographic evaluation of rheumatoid arthritis and related condition by standard reference films. Acta Radiol Diagn 18:481–491Google Scholar
  17. 17.
    Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH (1992) Derivation of the SLEDAI. A disease activity index for lupus patients. Arthritis Rheum 35:630–640PubMedCrossRefGoogle Scholar
  18. 18.
    Gladman D, Ginzler E, Goldsmith C, Fortin P, Liang M, Urowitz M et al (1996) The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum 39:363–369PubMedCrossRefGoogle Scholar
  19. 19.
    STATISTICA for Windows (5.1 edn) (1998) Statsoft, TulsaGoogle Scholar
  20. 20.
    Strand V, Scott DL, Emery P, Kalden JR, Smolen JS, Cannon GW et al (2005) Physical function and health related quality of life: analysis of 2-year data from randomized, controlled studies of leflunomide, sulfasalazine, or methotrexate in patients with active rheumatoid arthritis. J Rheumatol 32:590–601PubMedGoogle Scholar
  21. 21.
    Gilboe IM, Kvien TK, Husby G (1999) Health status in systemic lupus erythematosus compared to rheumatoid arthritis. J Rheumatol 26:1694–1700PubMedGoogle Scholar
  22. 22.
    Rinaldi S, Doria A, Salaffi F, Ermani M, Iaccarino L, Ghirardello A et al (2004) Health-related quality of life in Italian patients with systemic lupus erythematosus. I. Relationship between physical and mental dimension and impact of age. Rheumatology 43:1574–1579PubMedCrossRefGoogle Scholar
  23. 23.
    Bruce I, Mak V, Hallett D, Gladman D, Urowitz M (1999) Factors associated with fatigue in patients with systemic lupus erythematosus. Ann Rheum Dis 58:379–381PubMedCrossRefGoogle Scholar
  24. 24.
    Fortin PR, Abrahamowicz M, Neville C, du Berger R, Clarke AE, Danoff D (1998) Impact of disease activity and cumulative damage on the health of lupus patients. Lupus 7:101–107PubMedCrossRefGoogle Scholar
  25. 25.
    Stoll T, Gordon C, Seifert B, Richardson K, Malik J, Bacon PA et al (1997) Consistency and validity of patient administered assessment of quality of life by the MOS SF-36: its association with disease activity and damage in patients with systemic lupus erythematosus. J Rheumatol 24:1608–1614PubMedGoogle Scholar
  26. 26.
    Gladman DD, Urowitz MB, Ong A, MacKinnon A (1996) Lack of correlation among the 3 outcomes describing SLE: disease activity, damage and quality of life. Clin Exp Rheumatol 14:305–308PubMedGoogle Scholar
  27. 27.
    Khanna S, Pal H, Pandey RM, Handa R (2004) The relationship between disease activity and quality of life in systemic lupus erythematosus. Rheumatology 43:1536–1540PubMedCrossRefGoogle Scholar
  28. 28.
    Dossaers-Bakker KW, de Buck M, van Zeben D, Zwinderman AH, Breedveld FC, Hazes JMW (1999) Long-term course and outcome of functional capacity in rheumatoid arthritis. Arthritis Rheum 42:1854–1860CrossRefGoogle Scholar
  29. 29.
    Stoll T, Sutcliffe N, Klaghofer R, Isenberg DA (2000) Do present damage and health perception in patients with systemic lupus erythematosus predict extent of future damage? A prospective study. Ann Rheum Dis 59:832–835PubMedCrossRefGoogle Scholar
  30. 30.
    Westaway MS, Rheeder P, Gumede T (2001) The effect of type 2 diabetes mellitus on health-related quality of life (HRQOL). Curationis 24:74–78PubMedGoogle Scholar

Copyright information

© Clinical Rheumatology 2006

Authors and Affiliations

  1. 1.Division of Rheumatology, Department of Medicine, Chris Hani Baragwanath HospitalUniversity of the WitwatersrandJohannesburgSouth Africa

Personalised recommendations